Reagents

Cytek Biosciences and Bio-Rad Laboratories have entered into a strategic development partnership.   Under the terms of the agreement, Bio-Rad’s new StarBright Dyes will be available to Cytek to develop and commercialise reagent products to support high-parameter applications on Aurora and Northern Lights flow cytometry systems.  StarBright Dyes have been designed to be stable with superior […]

Biosynth are experts in complex chemistry, peptides and key biological raw materials, providing more than half a million research products plus end-to-end manufacturing including discovery, optimisation, and scale up. Biosynth manufacture and source a vast range of chemical and biochemical products and provide a full range of products and services to support life science research […]

Medical technology company BD has recently released the BD Rhapsody TCR/BCR Multiomic Assay, a set of reagents that enables researchers to more easily and comprehensively analyse cells, providing a tool to advance research in autoimmune disorders, immuno-oncology and infectious diseases.   The multiomic assay supplies immunology researchers the specific reagents required to profile full-length T cell […]

Sino Biological has launched a panel of research reagents for the newly identified Omicron variant (B.1.1.529) of the SARS-CoV-2 virus. The new Omicron product line includes recombinant Omicron spike proteins (RBD, S1, and S-ECD trimer), monoclonal antibodies recognising the Omicron spike protein, and the Omicron pseudovirus assay CRO service. These reagents will help scientists and […]

PerkinElmer has entered into an agreement to acquire BioLegend, provider of life science antibodies and reagents, for approximately US$5.25 billion. The transaction will be the largest in PerkinElmer’s history and is expected to close by the end of the 2021 calendar year, subject to regulatory approvals and other customary closing conditions. BioLegend provides academic and […]

The Native Antigen Company has announced the launch of its SARS-CoV-2 Neutralisation Assay Development Kit. The kit can be used to identify and qualitatively assess the ability of antibodies to neutralise SARS-CoV-2-receptor binding, to support research into variants and their effects on natural and vaccine-induced patient immunity. The kit contains all the key reagents required […]

PerkinElmer has launched the first cell painting kit as part of its new portfolio of PhenoVue cellular imaging reagents. This new range of reagents leverages PerkinElmer’s expertise in cellular imaging and high-content screening and works alongside its microplates, automation, software and high-content screening instruments. With this entire screening workflow, researchers can better understand disease and […]